Assignee
GLAXOSMITHKLINE IP DEV LTD
GB·208 granted patents·213 pending applications·642 citations·filing 2013–2025
Top patents by PatentIndex Score
421 records- 0197US10336744B21AP E3 ligase directed proteolysis targeting chimeric moleculesGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 2, 2019·50 cites·2 claims
- 0296US9789100B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Oct 17, 2017·30 cites·18 claims
- 0396US9771424B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 26, 2017·30 cites·20 claims
- 0496US9738718B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 22, 2017·33 cites·20 claims
- 0596US9556152B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 31, 2017·29 cites·20 claims
- 0696US9035063B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted May 19, 2015·55 cites·8 claims
- 0795US9718848B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 1, 2017·30 cites·31 claims
- 0895US9624202B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 18, 2017·25 cites·26 claims
- 0994US11365190B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Jun 21, 2022·3 cites·18 claims
- 1094US8937071B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 20, 2015·59 cites·15 claims
- 1193US11492361B2Compounds useful in HIV therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Nov 8, 2022·3 cites·24 claims
- 1293US10981901B1Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 20, 2021·7 cites·10 claims
- 1392US11697665B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Jul 11, 2023·3 cites·20 claims
- 1491US11970480B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Granted Apr 30, 2024·2 cites·16 claims
- 1591US10870663B2Compounds useful in HIV therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Dec 22, 2020·3 cites·12 claims
- 1691US10513517B2Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 24, 2019·11 cites·3 claims
- 1790US10485806B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Nov 26, 2019·3 cites·10 claims
- 1890US10189820B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jan 29, 2019·9 cites·8 claims
- 1990US9994607B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jun 12, 2018·10 cites·16 claims
- 2089US10047115B2Cyclic dinucleotides useful for the treatment of inter alia cancerGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 14, 2018·12 cites·9 claims
- 2189US9988376B2Benzothiophene derivatives as estrogen receptor inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jun 5, 2018·9 cites·21 claims
- 2289US9914781B1Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 13, 2018·10 cites·6 claims
- 2388US10358427B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 23, 2019·11 cites·8 claims
- 2488US10272095B2NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 30, 2019·4 cites·18 claims
- 2587US10933070B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 2, 2021·2 cites·4 claims
- 2687US10640812B2Processes for the production of oligonucleotidesGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 5, 2020·3 cites·16 claims
- 2787US9993514B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jun 12, 2018·11 cites·12 claims
- 2887US9737505B2Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-prolineGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Aug 22, 2017·4 cites·16 claims
- 2987US9382238B2Pyridine derivatives as rearranged during transfection (RET) kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jul 5, 2016·9 cites·4 claims
- 3086US10899716B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 26, 2021·2 cites·2 claims
- 3186US10364266B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 30, 2019·5 cites·11 claims
- 3286US9102668B2Polymorphs and saltsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Aug 11, 2015·3 cites·4 claims
- 3385US10858631B2Methods for adeno-associated viral vector productionGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 8, 2020·5 cites·32 claims
- 3485US10590085B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 17, 2020·3 cites·31 claims
- 3585US10023568B2Naphthyridine derivatives useful as αvβ6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jul 17, 2018·5 cites·39 claims
- 3685US9216965B2Amino-quinolines as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2013·Granted Dec 22, 2015·9 cites·16 claims
- 3784US11547704B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 10, 2023·1 cites·4 claims
- 3884US11229646B2Method for treating gonorrhea with (2R)-2-({4-[(3,4-dihydro-2H-pyrano[2,3-C]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-1,2-dihydro-3H,8H-2A,5,8A-triazaacenaphthylene-3,8-dioneGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 25, 2022·1 cites·5 claims
- 3984US11130811B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Sep 28, 2021·1 cites·18 claims
- 4084US10683360B2Targeted protein degradationGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jun 16, 2020·4 cites·11 claims
- 4184US10450312B2Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 22, 2019·3 cites·82 claims
- 4284US10450341B2Cyclic di-nucleotides as modulators of STINGGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 22, 2019·6 cites·13 claims
- 4384US10292987B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 21, 2019·4 cites·10 claims
- 4484US10144733B2Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Dec 4, 2018·5 cites·13 claims
- 4584US2024300965A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 4683US11111262B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Sep 7, 2021·1 cites·4 claims
- 4783US10940154B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 9, 2021·3 cites·4 claims
- 4883US9956209B2Compounds αv β6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted May 1, 2018·4 cites·10 claims
- 4983US9918974B2Pyridone derivatives as rearranged during transfection (RET) kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Mar 20, 2018·3 cites·19 claims
- 5083US2023242642A1Antigen binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 421 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →